Finance

Lists
ASTH:NASDAQ
Astrana Health Inc
$40.36
+6.80%
(+2.57) 1D
Aug 14, 1:46:42 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ASTH...
Open
$37.69
High
$40.61
Low
$37.69
Mkt. cap
1.87B
Avg. vol.
580.52K
Volume
244.15K
52-wk high
$51.60
52-wk low
$18.08
Beta
0.87
Shares outstanding
45.02M
No. of employees
3K
Open
$37.69
High
$40.61
Low
$37.69
Mkt. cap
1.87B
Avg. vol.
580.52K
Volume
244.15K
52-wk high
$51.60
52-wk low
$18.08
Beta
0.87
Shares outstanding
45.02M
No. of employees
3K
News stories
From web sources and news partners
About Astrana Health Inc
CEO-
Employees3K
Founded1985
HeadquartersAlhambra, California, United States
SectorHealth care provider
Websiteastranahealth.com
Analyst ratings
Based on 8 analysts giving stock ratings to ASTH in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ASTH in the last 3 months.
Highest
Current $40.36
$65.00 (+61.05%)
Average
$52.83 (+30.90%)
Lowest
$41.00 (+1.59%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jailendra Singh
Truist Financial
Buy
Reiterated
$55.00
+36.3%
08/11/2026
David Larsen
BTIG
Buy
Maintained
$65.00
+61.1%
08/09/2026
Matthew Shea
Needham
Buy
Reiterated
$41.00
+1.6%
08/07/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
08/07/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$53.00
+31.3%
08/07/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/06/2026
Ryan Langston
TD Cowen
Buy
Reiterated
$50.00
+23.9%
07/14/2026
Jack Slevin
Jefferies
Buy
Reiterated
$53.00
+31.3%
06/30/2026
Michael Craig Jones
Bank of America Securities
Buy
Maintained
-
-
05/13/2026
Michael Ha
Robert W. Baird
Buy
Maintained
$45.00
+11.5%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
956.05M
950.53M
965.10M
972.52M
Cost of goods sold
858.86M
855.48M
859.36M
868.50M
Cost of revenue
858.86M
855.48M
859.36M
868.50M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
52.09M
61.05M
61.16M
54.15M
Operating expense
67.68M
77.45M
76.64M
69.70M
Total operating expenses
926.54M
932.93M
935.99M
938.20M
Operating income
29.51M
17.60M
29.11M
34.32M
Other non operating income
445.00K
2.10M
662.00K
-2.30M
EBT including unusual items
5.67M
7.51M
19.71M
27.21M
EBT excluding unusual items
16.78M
2.34M
19.21M
22.48M
Income tax expense
4.59M
944.00K
6.58M
8.76M
Effective tax rate
81.01%
12.58%
33.38%
32.19%
Other operating expenses
-
-
-
-
Net income
373.00K
6.00M
14.44M
19.74M
Net profit margin
0.04%
0.63%
1.50%
2.03%
Earnings per share
0.67
0.42
0.74
0.80
Interest and investment income
3.52M
3.99M
3.82M
5.91M
Interest expense
-17.72M
-22.52M
-16.10M
-16.00M
Net interest expenses
-14.20M
-18.53M
-12.28M
-10.09M
Depreciation and amortization charges
15.60M
16.40M
15.48M
15.55M
EBITDA
45.11M
34.00M
44.59M
49.87M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps